These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27417417)

  • 41. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
    Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
    J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T-cell-specific Sel1L deletion exacerbates EAE by promoting Th1/Th17-cell differentiation.
    Yao X; Wu Y; Xiao T; Zhao C; Gao F; Liu S; Tao Z; Jiang Y; Chen S; Ye J; Chen H; Long Q; Wang H; Zhou X; Shao Q; Qi L; Xia S
    Mol Immunol; 2022 Sep; 149():13-26. PubMed ID: 35696849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes.
    Wei J; Yuan Y; Chen L; Xu Y; Zhang Y; Wang Y; Yang Y; Peek CB; Diebold L; Yang Y; Gao B; Jin C; Melo-Cardenas J; Chandel NS; Zhang DD; Pan H; Zhang K; Wang J; He F; Fang D
    Nat Commun; 2018 Sep; 9(1):3659. PubMed ID: 30201971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity.
    Prado C; Contreras F; González H; Díaz P; Elgueta D; Barrientos M; Herrada AA; Lladser Á; Bernales S; Pacheco R
    J Immunol; 2012 Apr; 188(7):3062-70. PubMed ID: 22379034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
    Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
    J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.
    Nizri E; Irony-Tur-Sinai M; Lory O; Orr-Urtreger A; Lavi E; Brenner T
    J Immunol; 2009 Nov; 183(10):6681-8. PubMed ID: 19846875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System.
    Seki SM; Stevenson M; Rosen AM; Arandjelovic S; Gemta L; Bullock TNJ; Gaultier A
    J Immunol; 2017 Jun; 198(12):4607-4617. PubMed ID: 28507026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.
    Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X
    Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
    Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W
    Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hrd1 and ER-Associated Protein Degradation, ERAD, are Critical Elements of the Adaptive ER Stress Response in Cardiac Myocytes.
    Doroudgar S; Völkers M; Thuerauf DJ; Khan M; Mohsin S; Respress JL; Wang W; Gude N; Müller OJ; Wehrens XH; Sussman MA; Glembotski CC
    Circ Res; 2015 Aug; 117(6):536-46. PubMed ID: 26137860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Balanced Bcl-3 expression in murine CD4
    Mufazalov IA; Kuschmann J; Andruszewski D; Masri J; Gabriel LA; Adams P; Reissig S; Hövelmeyer N; Waisman A
    Eur J Immunol; 2017 Aug; 47(8):1335-1341. PubMed ID: 28598502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RNF157 attenuates CD4
    Wang P; Zhao J; Tan Y; Sheng J; He S; Chen Y; Nie D; You X; Luo J; Zhang Y; Hu S
    Theranostics; 2023; 13(11):3509-3523. PubMed ID: 37441600
    [No Abstract]   [Full Text] [Related]  

  • 56. GRAIL: a unique mediator of CD4 T-lymphocyte unresponsiveness.
    Whiting CC; Su LL; Lin JT; Fathman CG
    FEBS J; 2011 Jan; 278(1):47-58. PubMed ID: 21078124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Energy supplementation rescues growth restriction and female infertility of mice with hepatic HRD1 ablation.
    Chen L; Wei J; Zhu H; Pan H; Fang D
    Am J Transl Res; 2020; 12(5):2018-2027. PubMed ID: 32509196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GRAIL-Galleri: why the special treatment?
    Turnbull C; Wald N; Sullivan R; Pharoah P; Houlston RS; Aggarwal A; Hogarth S; McCartney M
    Lancet; 2024 Feb; 403(10425):431-432. PubMed ID: 38253053
    [No Abstract]   [Full Text] [Related]  

  • 59. Response to GRAIL-Galleri: why the special treatment?
    Johnson P
    Lancet; 2024 Feb; 403(10425):432-433. PubMed ID: 38253054
    [No Abstract]   [Full Text] [Related]  

  • 60. Endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls B-cell immunity through degradation of the death receptor CD95/Fas.
    Kong S; Yang Y; Xu Y; Wang Y; Zhang Y; Melo-Cardenas J; Xu X; Gao B; Thorp EB; Zhang DD; Zhang B; Song J; Zhang K; Zhang J; Zhang J; Li H; Fang D
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10394-9. PubMed ID: 27573825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.